Global Health Investment Corporation
Fund of fundsNew York · Seed–Series B · 1 people tracked
Investment thesis
GHIC invests in global health innovation with a focus on products and platforms addressing vaccine development, antibody research, and infectious disease challenges. The fund emphasizes ensuring that breakthrough health technologies developed are made accessible and affordable worldwide, operating through strategic partnerships with government, philanthropic, and private sector stakeholders to advance global health security.
Source: firm website, verified Jul 21, 2026.
Team · 1 people
from the firm's websiteLeadership executive in global health product development and innovative financing who established GHIC and launched its inaugural Global Health Investment Fund. Previously spent seventeen years at the International AIDS Vaccine Initiative (IAVI) structuring vaccine and antibody research agreements in HIV, tuberculosis, COVID-19, and emerging infectious diseases; and nearly two decades in international law and financial services. Member of the Council on Foreign Relations.
Frequently asked questions
- What stage does Global Health Investment Corporation invest at?
- Global Health Investment Corporation invests at the Seed, Series A, Series B stages.
- What sectors does Global Health Investment Corporation focus on?
- Global Health Investment Corporation focuses on Biotech, Digital Health, Healthtech, Impact & Social Good.
- Where is Global Health Investment Corporation located?
- Global Health Investment Corporation is headquartered in New York, US.
Similar investors
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Lerer Hippeau is an early-stage venture capital firm focused on identifying and backing founders before they achieve prominence. The firm actively invests across multiple sectors including AI/ML, healthtech, fintech, enterprise software, and other emerging technology areas.
Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. The firm invests in life science companies across all development stages and manages a diversified portfolio including equities, bonds, real estate, infrastructure, and private equity.
B Capital is a venture capital firm managing $12+ billion in assets under management with 200+ early to late-stage portfolio companies across 9 global locations. The firm operates dedicated stage-based funds supporting entrepreneurs throughout the company-building lifecycle.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.